share_log

Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179) CEO Jiuzhen Xu, the Company's Largest Shareholder Sees 10% Reduction in Holdings Value

Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179) CEO Jiuzhen Xu, the Company's Largest Shareholder Sees 10% Reduction in Holdings Value

上海阿拉丁生化科技有限公司, Ltd.(上海證券交易所代碼:688179)首席執行官徐久振,該公司的最大股東預計持股價值將減少10%
Simply Wall St ·  2023/10/20 02:11

Key Insights

主要見解

  • Insiders appear to have a vested interest in Shanghai Aladdin Biochemical TechnologyLtd's growth, as seen by their sizeable ownership
  • 60% of the business is held by the top 2 shareholders
  • Institutional ownership in Shanghai Aladdin Biochemical TechnologyLtd is 18%
  • 內部人士似乎在上海阿拉丁生化科技有限公司的增長中擁有既得利益,這一點從他們的大量所有權中可以看出
  • 60%的業務由最大的兩個股東持有
  • 上海阿拉丁生化科技有限公司機構持股18%

To get a sense of who is truly in control of Shanghai Aladdin Biochemical Technology Co.,Ltd. (SHSE:688179), it is important to understand the ownership structure of the business. With 60% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

要弄清楚誰真正控制了上海阿拉丁生化科技有限公司(上證號:688179),瞭解企業的股權結構是很重要的。擁有60%股份的個人內部人士擁有該公司的最大股份。也就是說,如果股價上漲,該集團將受益最大(如果股價下跌,該集團將損失最大)。

And last week, insiders endured the biggest losses as the stock fell by 10%.

上週,內部人士遭受了最大的損失,該股下跌了10%。

Let's delve deeper into each type of owner of Shanghai Aladdin Biochemical TechnologyLtd, beginning with the chart below.

讓我們從下面的圖表開始,更深入地瞭解上海阿拉丁生化科技有限公司的每一種類型的所有者。

Check out our latest analysis for Shanghai Aladdin Biochemical TechnologyLtd

請查看我們對上海阿拉丁生化科技有限公司的最新分析

ownership-breakdown
SHSE:688179 Ownership Breakdown October 20th 2023
上海證交所:688179所有權明細2023年10月20日

What Does The Institutional Ownership Tell Us About Shanghai Aladdin Biochemical TechnologyLtd?

機構持股對上海阿拉丁生化科技有限公司有何啟示?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

機構投資者通常將自己的回報與經常跟蹤的指數的回報進行比較.因此,他們通常確實會考慮收購被納入相關基準指數的較大公司.

As you can see, institutional investors have a fair amount of stake in Shanghai Aladdin Biochemical TechnologyLtd. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Shanghai Aladdin Biochemical TechnologyLtd, (below). Of course, keep in mind that there are other factors to consider, too.

如你所見,機構投資者在上海阿拉丁生化科技有限公司持有相當數量的股份。這可以表明該公司在投資界具有一定的公信力。然而,最好警惕依賴機構投資者帶來的所謂驗證。他們也一樣,有時也會犯錯。如果兩個大型機構投資者試圖同時拋售一隻股票,股價大幅下跌的情況並不少見。因此,值得查看一下上海阿拉丁生化科技有限公司過去的盈利軌跡(見下文)。當然,請記住,還有其他因素需要考慮。

earnings-and-revenue-growth
SHSE:688179 Earnings and Revenue Growth October 20th 2023
上海證交所:688179收益和收入增長2023年10月20日

We note that hedge funds don't have a meaningful investment in Shanghai Aladdin Biochemical TechnologyLtd. The company's CEO Jiuzhen Xu is the largest shareholder with 39% of shares outstanding. In comparison, the second and third largest shareholders hold about 21% and 4.3% of the stock. Interestingly, the second-largest shareholder, Liping Zhao is also Other Key Executive, again, pointing towards strong insider ownership amongst the company's top shareholders.

我們注意到,對沖基金在上海阿拉丁生化科技有限公司沒有有意義的投資。該公司首席執行長徐久珍是最大股東,持有39%的流通股。相比之下,第二大股東和第三大股東分別持有約21%和4.3%的股份。有趣的是,第二大股東趙麗萍也是另一位關鍵高管,他再次指出,公司最大股東中存在強大的內部人所有權。

To make our study more interesting, we found that the top 2 shareholders have a majority ownership in the company, meaning that they are powerful enough to influence the decisions of the company.

為了讓我們的研究更有趣,我們發現,前兩名股東擁有公司的多數股權,這意味著他們足夠強大,可以影響公司的決策。

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is a little analyst coverage of the stock, but not much. So there is room for it to gain more coverage.

雖然研究一家公司的機構持股可以增加你的研究價值,但研究分析師的建議以更深入地瞭解一隻股票的預期表現也是一個很好的做法。分析師對該股的報道不多,但也不多。因此,它有獲得更多報道的空間。

Insider Ownership Of Shanghai Aladdin Biochemical TechnologyLtd

上海阿拉丁生化科技有限公司的內部人持股

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

不同國家對內部人的定義可能略有不同,但董事會成員總是算數的。管理層最終要向董事會負責。然而,經理人擔任執行董事會成員並不少見,尤其是如果他們是創始人或首席執行官的話。

Insider ownership is positive when it signals leadership are thinking like the true owners of the company. However, high insider ownership can also give immense power to a small group within the company. This can be negative in some circumstances.

內部人持股是積極的,當它標誌著領導層像公司的真正所有者一樣思考時.然而,高內部人持股也可以給公司內部的一個小團體帶來巨大的權力.在某些情況下,這可能是負面的.

It seems that insiders own more than half the Shanghai Aladdin Biochemical Technology Co.,Ltd. stock. This gives them a lot of power. Given it has a market cap of CN¥3.5b, that means they have CN¥2.1b worth of shares. It is good to see this level of investment. You can check here to see if those insiders have been buying recently.

看來,內部人士持有上海阿拉丁生化科技有限公司一半以上的股票。這給了他們很大的權力。鑑於它的市值為人民幣35億元,這意味著他們擁有價值人民幣21億元的股票。很高興看到這樣的投資水準。你可以在這裡查看這些內部人士最近是否一直在買入。

General Public Ownership

一般公有制

The general public, who are usually individual investors, hold a 17% stake in Shanghai Aladdin Biochemical TechnologyLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

公眾通常是個人投資者,他們持有上海阿拉丁生化科技有限公司17%的股份。雖然這群人不一定能發號施令,但它肯定能對公司的運營方式產生真正的影響。

Private Company Ownership

私營公司所有權

We can see that Private Companies own 5.4%, of the shares on issue. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們可以看到,私營公司擁有5.4%的已發行股份。私營公司可能是關聯方。有時,內部人士通過持有一傢俬人公司來對上市公司感興趣,而不是以個人身分。雖然很難得出任何大致的中風結論,但值得注意的是,這是一個值得進一步研究的領域。

Next Steps:

接下來的步驟:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 3 warning signs for Shanghai Aladdin Biochemical TechnologyLtd (of which 1 is a bit unpleasant!) you should know about.

我發現看看到底是誰擁有一家公司是非常有趣的。但為了真正獲得洞察力,我們還需要考慮其他資訊。比如風險。每家公司都有它們,我們已經發現上海阿拉丁生化科技有限公司的3個警示標誌(其中1個有點不愉快!)你應該知道。

Ultimately the future is most important. You can access this free report on analyst forecasts for the company.

最終未來是最重要的那就是。您可以訪問此免費分析師對該公司的預測報告.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注:本文中的數位是使用過去12個月的數據計算的,指的是截至財務報表日期的最後一個月的12個月期間.這可能與全年的年度報告數位不一致.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論